Butein (Standard)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Butein (Standard)
Description :
Butein (Standard) is the analytical standard of Butein. This product is intended for research and analytical applications. Butein is a cAMP-specific PDE inhibitor with an IC50 of 10.4 μM for PDE4[1]. Butein is a specific protein tyrosine kinase inhibitor with IC50s of 16 and 65 μM for EGFR and p60c-src in HepG2 cells[2]. Butein sensitizes HeLa cells to Cisplatin through AKT and ERK/p38 MAPK pathways by targeting FoxO3a[3]. Butein is a SIRT1 activator (STAC) .Product Name Alternative :
2’,3,4,4’-tetrahydroxy Chalcone (Standard)UNSPSC :
12352005Target :
Apoptosis; Autophagy; EGFR; Phosphodiesterase (PDE) ; Reference StandardsType :
Reference StandardsRelated Pathways :
Apoptosis; Autophagy; JAK/STAT Signaling; Metabolic Enzyme/Protease; Others; Protein Tyrosine Kinase/RTKField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/butein-standard.htmlSmiles :
OC1=CC=C(C(/C=C/C2=CC(O)=C(O)C=C2)=O)C(O)=C1Molecular Formula :
C15H12O5Molecular Weight :
272.25References & Citations :
[1]Yu SM, et al. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.Eur J Pharmacol. 1995 Jun 23;280 (1) :69-77.|[2]Yang EB, et al. Butein, a specific protein tyrosine kinase inhibitor.Biochem Biophys Res Commun. 1998 Apr 17;245 (2) :435-8.|[3]Zhang L, et al. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.Int J Mol Med. 2015 Oct;36 (4) :957-66.Shipping Conditions :
Room temperatureScientific Category :
Reference StandardsCAS Number :
[487-52-5]
